Hikma Pharmaceuticals
HIK.L
#3281
Rank
NZ$8.44 B
Marketcap
NZ$40.81
Share price
2.57%
Change (1 day)
11.64%
Change (1 year)

EPS for Hikma Pharmaceuticals (HIK.L)

EPS in 2019 (TTM): N/A

In 2022 the company made an earnings per share (EPS) of NZ$1.53 a decrease over its 2021 EPS that were of NZ$3.31.

EPS history for Hikma Pharmaceuticals from 2002 to 2019

Annual EPS

Year EPS Change
2022NZ$1.53-53.98%
2021NZ$3.31-0.16%
2020NZ$3.32-9.06%
2019NZ$3.6571.62%
2018NZ$2.13-133.3%
2017NZ-$6.39-628.27%
2016NZ$1.21-47.47%
2015NZ$2.30-9.83%
2014NZ$2.5530.48%
2013NZ$1.96110.57%
2012NZ$0.9323.73%
2011NZ$0.75-19.65%
2010NZ$0.9325.67%
2009NZ$0.7434.54%
2008NZ$0.55-17.84%
2007NZ$0.6713.5%
2006NZ$0.598.67%
2005NZ$0.55-98.86%
2004NZ$47.8124711.32%
2003NZ$0.1968.25%
2002NZ$0.11